AMINOSYN 8.5% W/ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic
NDAINJECTIONINJECTABLE
Approved
Dec 1975
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 23h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN 8.5% W/ELECTROLYTES is a parenteral nutrition solution containing amino acids with essential electrolytes (magnesium, potassium, sodium, phosphate) delivered by injection. It provides nutritional support and electrolyte balance for patients unable to take nutrition orally or enterally. The formulation supplies amino acid substrates for protein synthesis while correcting electrolyte deficiencies in critically ill or post-surgical patients.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100); career roles focus on operational excellence and cost management rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
AMINOSYN careers emphasize operational and manufacturing excellence, with 25 linked positions primarily in Engineering, Quality, Manufacturing, and Commercial roles. Working on this product develops expertise in parenteral nutrition formulation, process optimization, regulatory compliance, and cost management in a mature market facing LOE.
EngineerQuality Inspector I
Worked on AMINOSYN 8.5% W/ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.